These provisional accounts were presented to the Board of Directors at its meeting on23rd August 2023. The audit process is in progress. The final consolidated financial statements for the year ended June 30, 2023 will be approved by the Board of Directors at a meeting scheduled for October 2023.

13.5% total revenues growth for the third quarter of this financial year, up to €1.3bn total revenues, supported by a broad-based good dynamics and recent acquisitions in the Nordics countries. Growth on a like-for-like basis of 10.2%.

Ramsay Santé has continued to support health systems in both France and Nordics countries despite being heavily impacted by numerous headwinds, including salary and procurement inflation, staff shortages.

9.8% total revenues growth for this quarter, strongly supported by good dynamics in the Nordics countries and recent acquisitions. Growth on a like-for-like basis of 4.9%.

The solid performance of the Nordic countries has led to an improvement in the results of the Ramsay Santé group, despite the persistent challenges of high inflation, a shortage of nursing and clinical staff and the ongoing pandemic, in which Ramsay Santé has continued to play a leading role in Europe.

After renegotiating its syndicated debt in April 2021 with a TLB linked to its ESG performance and issuing a Euro PP in December 2021, Ramsay Santé is pursuing its refinancing and sustainable commitment dynamic.

The solid performance of the Nordic countries has led to an improvement in the results of the Ramsay Santé group, despite the persistent challenges of high inflation, a shortage of nursing and clinical staff and the ongoing pandemic, in which Ramsay Santé has continued to play a leading role in Europe.

Unaudited turnover for the 9 months period ending 31 March 2022 amounted to €3,141.7m, up 6.7% compared to the same period of the previous year. Unaudited turnover for the 3 months period ending 31 March 2022 amounted to €1,104m, up 6,9% compared to the same period of the previous year.

The period significantly impacted by COVID waves during which Ramsay Santé have continued to play a key role, in both France and the Nordics, to take care of patients.

Confirmation of data published at the end of August 2021.

It is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021.

Strong financial results demonstrating the relevance of our strategic move as a global health provider in Continental Europe, in a Covid context where Ramsay Santé has kept on playing a critical role to take care of patients.

Results supported by government measures related to the first wave of the COVID crisis, a crisis in which Ramsay Santé continues to play a major role in serving patients in Europe.

Resilient results impacted by the Covid crisis, a crisis in which Ramsay Santé has been a key player in patient care in Continental Europe.

Satisfactory results which confirm our integrated care strategy and our leadership position in Europe

Confirmation of the figures published at the end of August 2019

Good results and solid perspectives

Solid results were recorded in the first six months, and, moreover, the successful acquisition of the CAPIO Group opens up bright prospects

Declining results in a still very negative pricing environment

Strong performance despite a year of further price cuts.